SEC Form 4 · accession 0001225208-17-005091
Merck & Co., Inc. · MRK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Adam H Schechter
Officer — EVP & Pres-Global Human Health
Period of report
Feb 27, 2017
Accepted (ET)
Mar 1, 2017 · 4:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000310158
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 27, 2017 | A | 39,970 | $65.85 | A | 39,970 | D | |
| Common StockF2 | holding | — | — | — | 130,216 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/14. Performance shares were paid out at 158 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2016.
- F2Holdings include shares acquired in dividend reinvestment transactions.